Download FREE Report Sample
Download Free sampleGene delivery uses physical, chemical, or viral means to introduce genetic material into cells, thereby amplifying or enhancing their natural functions and harnessing their full therapeutic potential. These techniques use relatively aggressive means to disrupt the cell membrane (from electrical currents to surface charged lipids) and introduce macromolecular cargoes into cells, thereby triggering directed cytoplasmic events.
Gene Delivery Technologies Market contains market size and forecasts of Gene Delivery Technologies in Global, including the following market information:
Global Gene Delivery Technologies Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Gene Delivery Technologies market was valued at 4147.4 million in 2021 and is projected to reach US$ 8107.1 million by 2028, at a CAGR of 10.0% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Biological Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Gene Delivery Technologies include Thermo Fisher Scientific, Inc., QIAGEN, Horizon Discovery Group Co., OriGene Technologies, Inc., Oxford Biomedica, SignaGen Laboratories, Vectalys, Takara Bio Inc. and Bio-Rad Laboratories, Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Gene Delivery Technologies companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Gene Delivery Technologies Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Gene Delivery Technologies Market Segment Percentages, by Type, 2021 (%)
Biological
Chemical
Physical
Global Gene Delivery Technologies Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Gene Delivery Technologies Market Segment Percentages, by Application, 2021 (%)
Gene Therapy
Cell Therapy
Vaccines
Research
Global Gene Delivery Technologies Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Gene Delivery Technologies Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Gene Delivery Technologies revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Gene Delivery Technologies revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Thermo Fisher Scientific, Inc.
QIAGEN
Horizon Discovery Group Co.
OriGene Technologies, Inc.
Oxford Biomedica
SignaGen Laboratories
Vectalys
Takara Bio Inc.
Bio-Rad Laboratories, Inc.
System Biosciences llc
Promega Corporation
Hoffmann-La Roche AG
Sirion-Biotech GmbH
Catalent Inc.
The Beijing Genomics Institute
LifeTech
Berry Genomics
Da An Gene
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
